PHG.BK Patrangsit Healthcare Group Public Company Limited
- Market cap
- THB 2.92B
- P/E
- 12.5x
- P/B
- 1.40x
- ROE
- 8.7%
- Dividend yield
- 5.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is PHG.BK undervalued?
Graham numberPHG.BK trades 11.8% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Patrangsit Healthcare Group Public Company Limited fundamental analysis
No fundamental analysis for Patrangsit Healthcare Group Public Company Limited yet.
Patrangsit Healthcare Group Public Company Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Patrangsit Healthcare Group Public Company Limited
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric skin, pediatric gastrointestinal tract and liver, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver m…
Full company profilePatrangsit Healthcare Group Public Company Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Patrangsit Healthcare Group Public Company Limited annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.97B | 2.04B | 2.14B | 2.27B | 2.51B | 2.39B |
| Gross Profit | 630M | 608M | 573M | 535M | 627M | 495M |
| Operating Income | 413M | 380M | 334M | 316M | 388M | 209M |
| EBITDA | - | 450M | 417M | 411M | 493M | 323M |
| Net Income | 317M | 293M | 259M | 252M | 309M | 181M |
| EPS | 1.06 | 0.98 | 0.86 | 0.84 | 1.03 | 0.60 |
| Balance Sheet | ||||||
| Total Assets | 1.48B | 1.62B | 2.36B | 2.42B | 2.60B | 2.49B |
| Total Liabilities | 705M | 649M | 400M | 368M | 392M | 404M |
| Shareholders' Equity | 772M | 975M | 1.96B | 2.05B | 2.21B | 2.09B |
| Cash & Short-term Investments | 189M | 184M | 275M | 129M | 338M | 517M |
| Cash Flow | ||||||
| Operating Cash Flow | 305M | 335M | 375M | 322M | 369M | 167M |
| Capital Expenditure | 57.7M | 87.5M | 140M | 111M | 72.1M | 173M |
| Free Cash Flow | 247M | 247M | 235M | 210M | 297M | -6.26M |
| Ratios | ||||||
| ROE | 41.1% | 30.0% | 13.2% | 12.3% | 14.0% | 8.7% |
| ROA | 21.5% | 18.0% | 11.0% | 10.4% | 11.9% | 7.2% |
| Net Profit Margin | 16.1% | 14.4% | 12.1% | 11.1% | 12.3% | 7.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Patrangsit Healthcare Group Public Company Limited dividends
- Dividend yield
- 5.03%
- Forward dividend
- 0.70 THB
- Payout ratio
- 47.5%
- Ex-dividend date
- May 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 147M | 0.49 | 47.5% |
| 2024 | THB 156M | 0.52 | 61.8% |
| 2023 | THB 380M | 1.27 | 146.4% |
| 2022 | THB 233M | 0.78 | 79.5% |
| 2021 | THB 100M | 0.33 | 31.5% |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Patrangsit Healthcare Group Public Company Limited
- Insiders 72.21%
- Institutions 0.00%
- Public & others 27.79%
- Shares outstanding 300M
- Free float 135M
Patrangsit Healthcare Group Public Company Limited company profile
- Company name
- Patrangsit Healthcare Group Public Company Limited
- Ticker
- PHG.BK
- Exchange
- Thailand Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Fiscal year end
- December
- Address
- 733/345, 733/359 Moo 8, Pathum Thani, Thailand, 12130
- Phone
- 66 2 998 9999
- Website
- patrangsit.com
About Patrangsit Healthcare Group Public Company Limited
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric skin, pediatric gastrointestinal tract and liver, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver medicine, neuro medicine, pulmonary and respiratory, cardiology, hematology, pediatric pulmonary and respiratory, skin clinic, and pediatrics allergy services. It also provides pediatrics heart and kidney, hemodialysis, health check-up, radiology and laboratory, men's health services, gastrointestinal tract endoscopy, chemotherapy, and women oncology services. Patrangsit Healthcare Group Public Company Limited was incorporated in 1984 and is based in Pathum Thani, Thailand.
Patrangsit Healthcare Group Public Company Limited management
8- Mr. Kanawat ChantaralawanCEO & Director
- Mr. Saran WangsuekulDeputy Chief Finance Officer
- Dr. Tanarat LayangkurMember of Executive Board
- Ms. Chandra LuangaramMember of Executive Board
- Ms. Wararat PruekarapornMember of Executive Board
- Mr. Apirak PreechsomboonDeputy Chief General Administration Officer
- Dr. Teeranan MitrpanonDirector of Rangsit General Hospital
- Ms. Supasjee BoonketDirector & Deputy Hospital Director